Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Pazdur

Showing results (1-10 of 151) with videos related to

Pageof 16
Sort By:
Journal of Gastroenterology|April 25, 2000
Recent advances in colorectal chemotherapy: oral fluorinated pyrimidines, oxaliplatin and irinotecanR Pazdur
American Journal of Clinical Oncology|December 1, 1989
Adjuvant therapy for colon carcinomaR Pazdur
Oncology (Williston Park, N.Y.)|February 12, 1998
Phase I and pharmacokinetic evaluations of UFT plus oral leucovorinR Pazdur
Oncology|January 1, 1997
Phase II study of UFT plus leucovorin in colorectal cancerR Pazdur
Oncology (Williston Park, N.Y.)|February 12, 1998
UFT: East meets West in drug developmentR Pazdur
British Journal of Haematology|October 1, 1991
Fluorouracil and recombinant interferon alfa-2a in advanced gastrointestinal neoplasmsR Pazdur
Journal of the National Cancer Institute|October 6, 2000
Response rates, survival, and chemotherapy trialsR Pazdur
Oncology (Williston Park, N.Y.)|August 12, 1999
Introduction. Beyond 5-fluorouracilR Pazdur
Oncology (Williston Park, N.Y.)|September 3, 1998
Irinotecan: toward clinical end points in drug developmentR Pazdur
Journal of Surgical Oncology. Supplement|January 1, 1993
Systemic therapies for unresectable primary hepatic tumorsD Moore, R Pazdur
Pageof 16

Showing results (1-10 of 151) with videos related to

Sort By:
Pageof 16
Journal of Gastroenterology|April 25, 2000
Recent advances in colorectal chemotherapy: oral fluorinated pyrimidines, oxaliplatin and irinotecanR Pazdur
American Journal of Clinical Oncology|December 1, 1989
Adjuvant therapy for colon carcinomaR Pazdur
Oncology (Williston Park, N.Y.)|February 12, 1998
Phase I and pharmacokinetic evaluations of UFT plus oral leucovorinR Pazdur
Oncology|January 1, 1997
Phase II study of UFT plus leucovorin in colorectal cancerR Pazdur
Oncology (Williston Park, N.Y.)|February 12, 1998
UFT: East meets West in drug developmentR Pazdur
British Journal of Haematology|October 1, 1991
Fluorouracil and recombinant interferon alfa-2a in advanced gastrointestinal neoplasmsR Pazdur
Journal of the National Cancer Institute|October 6, 2000
Response rates, survival, and chemotherapy trialsR Pazdur
Oncology (Williston Park, N.Y.)|August 12, 1999
Introduction. Beyond 5-fluorouracilR Pazdur
Oncology (Williston Park, N.Y.)|September 3, 1998
Irinotecan: toward clinical end points in drug developmentR Pazdur
Journal of Surgical Oncology. Supplement|January 1, 1993
Systemic therapies for unresectable primary hepatic tumorsD Moore, R Pazdur
Pageof 16